Squeeze away chemo fatigue? study tests sensory balls and relaxation for cancer patients
NCT ID NCT06499129
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether nursing interventions based on the Levine Conservation Model could help colorectal cancer patients cope with fatigue, nerve damage, and anxiety caused by chemotherapy. 68 patients receiving the FOLFOX regimen were taught to use sensory balls, progressive muscle relaxation, and received training. The goal was to see if these simple, drug-free techniques could improve their quality of life during treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- sensory ball, progressive relaxation exercise, training
- What this could lead to
- If effective, these simple nursing techniques could offer a low-cost way to reduce common chemotherapy side effects like fatigue, nerve pain, and anxiety.
- What could go wrong
- This is a small, single-center study with only 68 participants. Results may not apply to all patients, and the interventions may not provide significant relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
68 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between the ages of 18-75 * Diagnosed with primary and new colorectal cancer (Stage II and III), * The decision to start the FOLFOX treatment protocol has been taken, * Having a smartphone, * Being literate, * Ability to speak and understand Turkish, * Open to communication and cooperation. Exclusion Criteria: * History of neuropathy or diabetes, * History of hypothyroidism, renal failure, * Hearing, speech and vision problems, * Receiving radiotherapy or immunotherapy, * Psychiatric diagnosis or ongoing treatment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- Can video games calm anxious teens?
- Can a group program teach teens to cope before therapy starts?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days